Refine your search
Availability
-
Authors
-
Topics
- Biomarkers
- Budgets
- Cost-Benefit Analysis
- Costs and Cost Analysis
- Drug Costs
- Economics
- European Union
- Health Expenditures
- Health Services Accessibility
- Humans
- Needs Assessment
- Orphan Drug Production
- Precision Medicine
- Quality of Life
- Quality-Adjusted Life Years
- Rare Diseases
- United States
- United States Food and Drug Administration
- drug therapy
- economics
- Show more
- Show less
-
Languages